Liberty Media Corporation Reports Second Quarter 2024 Financial Results
Contacts Shane Kleinstein (720) 875-5432 Liberty Media Corporation (“Liberty Media” or “Liberty”) (NASDAQ: LSXMA, LSXMB, LSXMK, FWONA, FWONK, LLYVA, LLYVK)...
Contacts Shane Kleinstein (720) 875-5432 Liberty Media Corporation (“Liberty Media” or “Liberty”) (NASDAQ: LSXMA, LSXMB, LSXMK, FWONA, FWONK, LLYVA, LLYVK)...
Contacts Shane Kleinstein (720) 875-5432 Liberty Media Corporation (“Liberty Media” or “Liberty”) (NASDAQ: LSXMA, LSXMB, LSXMK, FWONA, FWONK, LLYVA, LLYVK)...
LAS VEGAS, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified...
Second Quarter 2024 Highlights: NEW YORK, Aug. 8, 2024 /PRNewswire/ -- Lindblad Expeditions Holdings, Inc. (NASDAQ: LIND; the "Company" or...
PARSIPPANY, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC) today announced financial and operating results...
SOMERSET, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell...
Contacts Shane Kleinstein (720) 875-5432 Liberty Broadband Corporation (“Liberty Broadband”) (Nasdaq: LBRDA, LBRDK, LBRDP) today reported second quarter 2024 results....
Contacts Shane Kleinstein (720) 875-5432 Liberty Broadband Corporation (“Liberty Broadband”) (Nasdaq: LBRDA, LBRDK, LBRDP) today reported second quarter 2024 results....
Contacts Shane Kleinstein (720) 875-5432 Liberty Broadband Corporation (“Liberty Broadband”) (Nasdaq: LBRDA, LBRDK, LBRDP) today reported second quarter 2024 results....
BEIJING, Aug. 09, 2024 (GLOBE NEWSWIRE) -- 36Kr Holdings Inc. ("36Kr" or the "Company" or "We") (NASDAQ: KRKR), a prominent...
PLANO, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Katapult Holdings, Inc. (NASDAQ: KPLT), an e-commerce-focused financial technology company, announced today...
PLANO, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Katapult Holdings, Inc. (NASDAQ: KPLT), an e-commerce-focused financial technology company, announced today...
Q2 2024 product revenues increased 84% compared to the same period in 2023 Defense product revenues increased 106% partially offset...
TROY, Mich. , Aug. 08, 2024 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today...
TROY, Mich. , Aug. 08, 2024 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today...
Tel Aviv, Israel, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW),...
- Mehrere klinische Meilensteine im gesamten Portfolio für 2024 erwartet, darunter zwei Phase-II-Studien zur Bewertung von Belrestotug + Dostarlimab bei...
Iteris Shareholders to Receive $7.20 Per Share in Cash, Representing Significant Premium of 68% Contacts Iteris Media & Investor Relations...
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development...
Contacts IR CONTACT Paul Bartolai or Noel Ryan ISSC@val-adv.com Innovative Solutions & Support, Inc. (Nasdaq: ISSC) ("IS&S" or the "Company"),...
WATERTOWN, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,...
– Initiation of Phase 1 CALiPSO-1 Trial of CNTY-101 in Systemic Lupus Erythematosus, marking strategic expansion into autoimmune disease; protocol...
HSINCHU, Aug. 9, 2024 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 andNasdaq: IMOS), an industry...
ContactsIngles Markets, Inc. Pat Jackson, Chief Financial Officer pjackson@ingles-markets.com (828) 669-2941 (Ext. 223) Ingles Markets, Incorporated (NASDAQ: IMKTA) today reported...
Contacts Media Wendy Goldberg Chief Communications Officer (212) 377-1105 wendygoldberg@iheartmedia.com Investors Mike McGuinness EVP, Deputy CFO, and Head of Investor...
JENA, Germany, Aug. 08, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today...
OLD GREENWICH, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (Nasdaq: HSON) ("Hudson Global" or "the Company"), a...
$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024The company is exploring the potential for...
HOLLISTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for...
SAN DIEGO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical...
Seoul, South Korea, Aug. 09, 2024 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and...
LAS VEGAS, NV, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Golden Matrix Group Inc. (NASDAQ: GMGI), a developer and licensor of...
Topline Results From MAD Phase 1 Study of GT-02287 on Track for August 2024 With Full Presentation at Upcoming Medical...
Contacts Shane Kleinstein (720) 875-5432 Liberty Media Corporation (“Liberty Media” or “Liberty”) (NASDAQ: LSXMA, LSXMB, LSXMK, FWONA, FWONK, LLYVA, LLYVK)...
Contacts Shane Kleinstein (720) 875-5432 Liberty Media Corporation (“Liberty Media” or “Liberty”) (NASDAQ: LSXMA, LSXMB, LSXMK, FWONA, FWONK, LLYVA, LLYVK)...
NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Five Below, Inc. ("FIVE" or the...
ATLANTA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet...
Contacts Investor Relations and Press Contacts: Stan Kovler Vice President, Corporate Strategy & Investor Relations Extreme Networks 919-595-4196 skovler@extremenetworks.com Amy...
– Completed Phase 1 SAD and MAD trial of EDG-7500 in healthy volunteers; Dosing patients in Phase 2 CIRRUS-HCM trial...
Second Quarter 2024 GAAP EPS of $0.90, compared to $0.78 in 2023 Second Quarter 2024 Adjusted EPS (Non-GAAP) of $0.90,...